29772 Federal Register / Vol. 75, No. 102 / Thursday, May 27, 2010 / Notices 

Contact Person: Carol Hamelink, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4192, 

MSC 7850, Bethesda, MD 20892, (301) 213– 

9887, hamelinc@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Health and Related Behaviors of 

Individuals and Populations. 

Date: June 23, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: Karin F. Helmers, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3166, 

MSC 7770, Bethesda, MD 20892, 301–254– 

9975, helmersk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Non-HIV Anti-Infective 

Therapeutics. 

Date: June 23–24, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications, 

Place: George Washington University Inn, 

824 New Hampshire Avenue, NW., 

Washington, DC 20037. 

Contact Person: Rossana Berti, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3191, 

MSC 7846, Bethesda, MD 20892, 301–402– 

6411, bertiros@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Sensory, Motor, and Cognitive 

Neuroscience. 

Date: June 23, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, NW., Washington, DC 

20037. 

Contact Person: John Bishop, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7844, Bethesda, MD 20892, (301) 408– 

9664, bishopj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; ARRA: 

Chronic Fatigue Syndrome, Fibromyalgia 

Syndrome, and Temporomandibular Disorder 

Competitive Revisions. 

Date: June 23, 2010. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications, 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Lynn E Luethke, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5166, 

MSC 7844, Bethesda, MD 20892, (301) 806– 

3323, luethkel@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflicts: Lung Host Defense and Cystic 

Fibrosis Applications. 

Date: June 23, 2010. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Everett E Sinnett, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2178, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1016, sinnett@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Risk Prevention and Health 

Behavior. 

Date: June 23–25, 2010. 

Time: 7 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Pier 5 Hotel, 711 Eastern Avenue, 

Baltimore, MD 21202. 

Contact Person: Claire E. Gutkin, PhD, 

MPH, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3138, 

MSC 7759, Bethesda, MD 20892, 301–594– 

3139, gutkincl@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: May 21, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–12788 Filed 5–26–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee, (HICPAC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting for the 

aforementioned committee: 

Times and Dates: 9 a.m.–5 p.m., June 

17, 2010; 9 a.m.–12 p.m., June 18, 2010. 

Place: CDC, Global Communications 

Center, Building 19, Auditorium B3, 

1600 Clifton Road, NE., Atlanta, Georgia 

30333. 

Status: This meeting is open to the 

public, limited only by the space 

available. Please register for the meeting 

online at http://www.cdc.gov/hicpac or 

by sending an e-mail to hicpac@cdc.gov. 

Purpose: The Committee is charged 

with providing advice and guidance to 

the Secretary, the Assistant Secretary for 

Health, the Director, CDC, and the 

Director, National Center for Emerging 

and Zoonotic Infectious Diseases 

(NCEZID) regarding (1) The practice of 

healthcare infection control; (2) 

strategies for surveillance, prevention, 

and control of infections (e.g., 

nosocomial infections), antimicrobial 

resistance, and related events in settings 

where healthcare is provided; and (3) 

periodic updating of guidelines and 

other policy statements regarding 

prevention of healthcare-associated 

infections and healthcare-related 

conditions. 

Matters to be Discussed: The agenda 

will include: Updates on CDC’s 

activities for healthcare associated 

infections; the draft guideline for the 

Prevention of Norovirus Gastroenteritis 

Outbreaks in Healthcare Settings; the 

draft guideline for prevention of 

infections among patients in neonatal 

intensive care units (NICU); the draft 

guideline for Infection Control in 

Healthcare Personnel; and a discussion 

of infection control in ambulatory care 

settings. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Michelle King, HICPAC, Division of 

Healthcare Quality Promotion, National 

Center for Emerging and Zoonotic 

Infectious Diseases, CDC, 1600 Clifton 

Road, N.E., Mailstop A–07, Atlanta, 

Georgia 30333 Telephone (404) 639– 

2936. E-mail: hicpac@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: May 19, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–12749 Filed 5–26–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

In accordance with section 10(d) of 

the Federal Advisory Committee Act (5 

U.S.C., Appendix 2), announcement is 

made of a Health Care Policy and 


wwoods2 on DSK1DXX6B1PROD with NOTICES
Federal Register / Vol. 75, No. 102 / Thursday, May 27, 2010 / Notices 29773 

Research Special Emphasis Panel (SEP) 

meeting. 

A Special Emphasis Panel is a group 

of experts in fields related to health care 

research who are invited by the Agency 

for Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10 (d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b (c)(6). Grant 

applications for the Recovery Act 2009 

Limited Competition: Prospect 

Studies—Building New Clinical 

Infrastructure for CE (R01) applications 

are to be reviewed and discussed at this 

meeting. These discussions are likely to 

reveal personal information concerning 

individuals associated with the 

applications. This information is 

exempt from mandatory disclosure 

under the above-cited statutes. 

SEP Meeting on: Recovery Act 2009 

Limited Competition: Prospect Studies— 

Building New Clinical Infrastructure for CE 

(R01). 

Dates: June 16, 2010. (Open on June 16 

from 8 a.m. to 8:15 a.m. and closed for the 

remainder of the meeting.) 

Place: Hyatt Regency Hotel, 7400 

Wisconsin Avenue, 1 Bethesda Metro Center, 

Conference Room TBD, Bethesda, MD 20814. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

nonconfidential portions of this meeting 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Room 

2038, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for this meeting are subject 

to change as priorities dictate. 

Dated: May 13, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–12546 Filed 5–26–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

In accordance with section 10(d) of 

the Federal Advisory Committee Act (5 

U.S.C., Appendix 2), announcement is 

made of a Health Care Policy and 

Research Special Emphasis Panel (SEP) 

meeting. 

A Special Emphasis Panel is a group 

of experts in fields related to health care 

research who are invited by the Agency 

for Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10(d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications for the OS ARRA: 

Enhancing Registries for Quality 

Improvement and Comparative 

Effectiveness (RO 1) applications are to 

be reviewed and discussed at this 

meeting. These discussions are likely to 

reveal personal information concerning 

individuals associated with the 

applications. This information is 

exempt from mandatory disclosure 

under the above-cited statutes. 

SEP Meeting on: OS ARRA: Enhancing 

Registries for Quality Improvement and 

Comparative Effectiveness (R01). 

Dates: June 18, 2010. (Open on June 18 

from 8 a.m. to 8:15 a.m. and closed for the 

remainder of the meeting.) 

Place: Crowne Plaza Hotel, 3 Research 

Court, Conference Room TBD, Rockville, MD 

20852. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

non-confidential portions of this meeting 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Room 

2038, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for this meeting are subject 

to change as priorities dictate. 

Dated: May 13, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–12544 Filed 5–26–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Collaborative 

Interdisciplinary Team Science—Nuclear 

Receptors. 

Date: June 10, 2010. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892. (Telephone 

Conference Call.) 

Contact Person: Robert Wellner, PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 757, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452. (301) 594–4721. 

rw175w@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Metabolic Disease 

and Pregnancy. 

Date: June 10, 2010. 

Time: 3:30 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892. (Telephone 

Conference Call.) 

Contact Person: Carol J. Goter-Robinson, 

PhD, Scientific Review Officer, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 748, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452. (301) 

594–7791. 

goterrobinsonc@extra.niddk.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 


wwoods2 on DSK1DXX6B1PROD with NOTICES